The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Nutrient Requirements of Nonhuman Primates: Second Revised Edition, 2003
TABLE 5-1 Common names, scientific names, and short-form designations of fatty acids
Common Name
Scientific Name
Short-Form Designation
Butyric acid
butanoic acid
C4:0
Caproic acid
hexanoic acid
C6:0
Caprylic acid
octanoic acid
C8:0
Capric acid
decanoic acid
C10:0
Lauric acid
dodecanoic acid
C12:0
Myristic acid
tetradecanoic acid
C14:0
Palmitic acid
hexadecanoic acid
C16:0
Stearic acid
octadecanoic acid
C18:0
Palmitoleic acid
9-hexadecaenoic acid
C16:1 n-7 cis
Oleic acid
9-octadecaenoic acid
C18:1 n-9 cis
Elaidic acid
9-octadecaenoic acid
C18:1 n-9 trans
Linoleic acid
9,12-octadecadienoic acid
C18:2 n-6,9 all cis
α-Linolenic acid
9,12,15-octadecatrienoic acid
C18:3 n-3,6,9 all cis
γ-Linolenic acid
6,9,12-octadecatrienoic acid
C18:3 n-6,9,12 all cis
Arachidic acid
eicosanoic acid
C20:0
Behenic acid
docosanoic acid
C22:0
Eicosenoic acid
11-eicosenoic acid
C20:1 n-9 cis
Erucic acid
13-docosaenoic acid
C22:1 n-9 cis
Brassidic acid
13-docosaenoic acid
C22:1 n-9 trans
Nervonic acid
15-tetracosaenoic acid
C24:1 n-9 cis
Dihomo-γ-linolenic acid
8,11,14-eicosatrienoic acid
C20:3 n-6,9,12 all cis
Arachidonic acid
5,8,11,14-eicosatetraenoic acid
C20:4 n-6,9,12,15 all cis
Timnodonic acid
5,8,11,14,17-eicosapentaenoic acid
C20:5 n-3,6,9,12,15 all cis
Clupanodonic acid
7,10,13,16,19-docosapentaenoic acid
C22:5 n-3,6,9,12,15 all cis
Docosahexaenoic acid
4,7,10,13,16,19-docosahexaenoic acid
C22:6 n-3,6,9,12,15,18 all cis
sider the most common dietary n-6 and n-3 fatty acids, linoleate and α-linolenate, as truly essential since these fatty acids must be ingested. Additional long chain polyunsaturated fatty acids can be constructed from these fatty acids, but ingestion of fatty acids with the n-3 and n-6 double bonds is a true requirement.
FAT ABSORPTION
In response to entry of fat into the intestine during digestion of a meal, the liver secretes bile into the gut; with the help of intestinal peristalsis, food fats are emulsified. Simultaneously, the pancreas secretes digestive enzymes, including lipases and esterases, into the small intestine. Fat digestion begins at the surface of emulsion particles with pancreatic lipase-catalyzed hydrolysis of triacylglycerol molecules into two fatty acids and a monoacylglyceride. These products of initial lipolytic activity and bile salts are active in further breakdown of emulsion particles and, with phospholipid and cholesterol bile micelles, form the micellar phase from which lipid absorption is maximal. In most laboratory studies of nonhuman primates, fat digestion and absorption were essentially quantitative, with less than 5% of dietary fat lost in the feces; this was true in a wide array of types and amounts (up to 40% of ME) of fat ingested (L. Rudel and P. Huth, unpublished). The processes of fat digestion and absorption also facilitate the absorption of cholesterol and fat-soluble vitamins from the intestine. These molecules are incorporated into emulsion particles and micelles, from which they pass into the enterocyte. However, only about 50% of cholesterol is absorbed from the intestine (Rudel et al., 1994; Wilson and Rudel, 1994), though some of the molecular processes involved are different for sterols and fatty acids.
Once inside the intestinal enterocyte, fatty acids and glycerides are reassembled into triacylglycerol molecules and incorporated into newly forming chylomicrons that include a protein, apolipoprotein B48. Nonhuman primates and humans share the characteristic presence of only apolipoprotein B48 in the intestine for transport of TAGs in chylomicrons, in contrast with the liver, where only apolipoprotein B100 is used for TAG secretion in very-low-density lipoproteins (VLDLs) (Klein and Rudel, 1983). Newly absorbed cholesterol is also esterified and incorporated into chylomicrons, although it makes up only about one percent (by mass) of these particles.
Capture of high-energy fatty acids from chylomicrons is efficient. The chylomicron particles are secreted by the enterocytes into basolateral spaces, where they cross into the lymphatic lacteals and enter the body via the thoracic lymph duct. This pathway of entry into the bloodstream directs fats first to the peripheral tissues, where interactions with lipoprotein lipase (LPL), attached to the endothelial cells of most tissues, can occur. Removal of TAG molecules from chylomicrons then proceeds with the LPL-catalyzed hydrolysis of TAGs into two fatty acids and a monoacylglyceride. In this form, the molecules pass across cell membranes and enter cells. In adipose tissue, TAG molecules are reassembled and stored for later use. In most other